Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Dec 3, 2021

Accession no.
0001209191-21-067893
Filed
Dec 3, 2021
Trade date
Nov 1-30, 2021
Filing delay
32 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $2.40K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockPPurchaseAcquired+42$2.67+$112.1418,102Direct
Nov 2, 2021Common StockPPurchaseAcquired+42$2.63+$110.4618,144Direct
Nov 3, 2021Common StockPPurchaseAcquired+42$2.71+$113.8218,186Direct
Nov 4, 2021Common StockPPurchaseAcquired+42$2.73+$114.6618,228Direct
Nov 5, 2021Common StockPPurchaseAcquired+42$2.71+$113.8218,270Direct
Nov 8, 2021Common StockPPurchaseAcquired+42$2.95+$123.918,312Direct
Nov 9, 2021Common StockPPurchaseAcquired+42$3.21+$134.8218,354Direct
Nov 10, 2021Common StockPPurchaseAcquired+42$2.94+$123.4818,396Direct
Nov 11, 2021Common StockPPurchaseAcquired+42$2.83+$118.8618,438Direct
Nov 12, 2021Common StockPPurchaseAcquired+42$2.67+$112.1418,480Direct
Nov 15, 2021Common StockPPurchaseAcquired+42$2.71+$113.8218,522Direct
Nov 16, 2021Common StockPPurchaseAcquired+42$2.66+$111.7218,564Direct
Nov 17, 2021Common StockPPurchaseAcquired+42$2.58+$108.3618,606Direct
Nov 18, 2021Common StockPPurchaseAcquired+42$2.58+$108.3618,648Direct
Nov 19, 2021Common StockPPurchaseAcquired+42$2.55+$107.118,690Direct
Nov 22, 2021Common StockPPurchaseAcquired+42$2.35+$98.718,732Direct
Nov 23, 2021Common StockPPurchaseAcquired+42$2.29+$96.1818,774Direct
Nov 24, 2021Common StockPPurchaseAcquired+42$2.31+$97.0218,816Direct
Nov 26, 2021Common StockPPurchaseAcquired+42$2.26+$94.9218,858Direct
Nov 29, 2021Common StockPPurchaseAcquired+42$2.23+$93.6618,900Direct
Nov 30, 2021Common StockPPurchaseAcquired+42$4.61+$193.6218,942Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)